Ablynx has posted rheumatoid arthritis data showing vobarilizumab can compete with Roche’s Actemra, but doubts remain about whether AbbVie will buy the drug.

Carmot Therapeutics has secured its second major partnership. The latest is a discovery and licensing deal with Roche’s Genentech.

Pfizer and research partner Merck KGaA have begun late-stage testing of their experimental checkpoint inhibitor avelumab with chemo in certain ovarian cancer…

Less than a week after stumping up cash for a one-drug-wonder biotech (and an option to buy it out), Japan’s Takeda has struck another biotech deal, this time…

Herbert Stadler’s Ellersbrook has partnered with Evotec to take a NASH program to the point it can be spun out or flipped to a biopharma company.

Despite the problems in China, Pfizer is betting big on its first biotech space in the region, stumping up £$350 million for a new biotech center that it hopes…

Epizyme has nabbed a partner in Roche’s Genentech for its tazemetostat and they are proceeding with a combination trial for the candidate in a subgroup of NHL…

Zealand Pharma has teamed up with Beta Bionics to advance an artificial pancreas into the clinic this year.